Capricor Therapeutics Inc (CAPR)
6.20
+0.56
(+9.93%)
USD |
NASDAQ |
May 17, 16:00
6.22
+0.02
(+0.32%)
After-Hours: 20:00
Capricor Therapeutics 1 Year Total Returns (Daily): 42.69% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | 42.69% |
May 16, 2024 | 33.02% |
May 15, 2024 | 27.21% |
May 14, 2024 | 29.03% |
May 13, 2024 | 34.99% |
May 10, 2024 | 29.90% |
May 09, 2024 | 34.49% |
May 08, 2024 | 37.69% |
May 07, 2024 | 39.29% |
May 06, 2024 | 41.07% |
May 03, 2024 | 42.45% |
May 02, 2024 | 39.36% |
May 01, 2024 | 36.32% |
April 30, 2024 | 35.48% |
April 29, 2024 | 37.02% |
April 26, 2024 | 36.96% |
April 25, 2024 | 31.04% |
April 24, 2024 | 23.83% |
April 23, 2024 | 16.99% |
April 22, 2024 | 19.90% |
April 19, 2024 | 18.44% |
April 18, 2024 | 19.67% |
April 17, 2024 | 29.37% |
April 16, 2024 | 35.39% |
April 15, 2024 | 33.79% |
Date | Value |
---|---|
April 12, 2024 | 47.41% |
April 11, 2024 | 45.22% |
April 10, 2024 | 48.58% |
April 09, 2024 | 57.89% |
April 08, 2024 | 57.42% |
April 05, 2024 | 60.38% |
April 04, 2024 | 60.67% |
April 03, 2024 | 61.52% |
April 02, 2024 | 63.27% |
April 01, 2024 | 68.13% |
March 28, 2024 | 65.61% |
March 27, 2024 | 64.72% |
March 26, 2024 | 53.16% |
March 25, 2024 | 60.92% |
March 22, 2024 | 49.07% |
March 21, 2024 | 56.36% |
March 20, 2024 | 52.90% |
March 19, 2024 | 56.45% |
March 18, 2024 | 55.76% |
March 15, 2024 | 42.95% |
March 14, 2024 | 32.97% |
March 13, 2024 | 31.13% |
March 12, 2024 | 27.16% |
March 11, 2024 | 25.00% |
March 08, 2024 | 24.66% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-84.22%
Minimum
Apr 02 2020
478.7%
Maximum
Mar 10 2021
17.43%
Average
-1.87%
Median
Jan 17 2024
1 Year Total Returns (Daily) Benchmarks
Sarepta Therapeutics Inc | -11.69% |
PTC Therapeutics Inc | -43.22% |
Solid Biosciences Inc | 45.53% |
Inovio Pharmaceuticals Inc | 38.77% |
Stereotaxis Inc | 24.26% |